Follow on Google News News By Tag * Pharmaceutical * Uzbekistan * Ratings * Drug * Healthcare * Uzpharmsanoat * Regime * Medical * Security * Limits * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | New Market Study Published: Uzbekistan Pharmaceuticals & Healthcare Report Q4 2010New Healthcare research report from Business Monitor International is now available from Fast Market Research
The pharmaceutical sector has been a priority for the government, at least according to its official pronouncements. Uzpharmsanoat, the state-controlled pharmaceutical holding, has attracted a number of joint-venture partners to develop manufacturing in the country. For foreign pharmaceutical players willing to entertain high levels of risk, Uzbekistan's market of 30mn, fast-growing economy and pent up demand make it one of the most attractive in the Central and Eastern European (CEE) region. Still, the country remains the worst major market to do business in the region according to BMI's Business Environment Ratings, with the recent unrest in neighbouring Kyrgyzstan underlining the dangers of poverty, corruption and ethnic tensions in the Ferghana valley and wider region. The regime of Islam Karimov has pursued, as have those in other CIS countries, an import substitution regime aimed at lowering dependency on drug imports (and accompanying exchange-rate and security concerns) as well as getting a bigger slice of the lucrative margin industry for local players. Practically, the government passed a new law on pharmaceuticals earlier this year which aims to better punish counterfeiters and which limits the licence term for pharmaceutical producers to five years. Uzpharmsanoat is in the middle of a US$30mn modernisation programme due to be completed at the end of 2011. The key for the state is to attract outside technology and investment. Notably, despite a business environment that is palpably more difficult than neighbouring Kazakhstan, Uzbekistan has benefited from a larger population and the existence of a big statebacked player with access to capital and a high degree of political security. Local industry sources report that a project to build a GMP-compliant vaccines factory with Hungary's Omnivest is going ahead. In July 2010, local media reported that Korean Trust Investment Trading was building a US$4mn pharmaceutical packaging factory as part of a 50%-50% joint venture with Uzpharmsanoat due to open by the end of the year in the Navoi Free Industrial-Economic Zone (NFIEZ). Japan's Overseas Medical Equipment Technical Assistance (OMETA) is reportedly eyeing the same region to develop medical equipment production. Grimly, unrest in Kyrgyzstan, along with the lack of production capacity in Turkmenistan and Tajikistan mean Uzbekistan has a potential regional role - but the state would benefit greatly if it dealt with notorious customs delays and was less suspicious of foreign NGOs. For more information or to purchase this report, go to: - http://www.fastmr.com/ Report Table of Contents: Executive Summary SWOT Analysis - Uzbekistan Pharmaceuticals And Healthcare Industry SWOT Pharmaceutical Business Environment Ratings - Table: Emerging Europe Pharmaceutical Business Environment Ratings, Q410 - Limits To Potential Returns - Risks To Realisation Of Returns Uzbekistan - Market Summary Regulatory Regime - Counterfeit Drugs - Intellectual Property Rights - Pricing and Reimbursement Industry Developments - Epidemiology - Healthcare Sector - Healthcare Sector Reforms - Pharmaceutical Industry - Pharmaceutical Sector Reforms - Pharmaceutical Industry Developments - Pharmaceutical Wholesale and Retail - Research and Development - International Cooperation - Medical Devices Industry Forecast Scenario - Overall Market Forecast - Key Growth Factors - Industry - Key Growth Factors - Macroeconomic - Table: Uzbekistan - Economic Activity - Prescription Drug Market Forecast - Top Ten ATC Level 2 Codes In Uzbekistan By Sales, 2007-2008 - Patented Drug Market Forecast - Generic Drug Market Forecast - OTC Drug Market Forecast - Pharmaceutical Export/Import Forecast - Other Healthcare Data Forecasts - Key Risks to BMI's Forecasts Competitive Landscape - Table: The Top Ten Drugmakers In Uzbekistan During 2007/08 According To Sales - Table: The Top Ten Trade Names In Uzbekistan During 2007/08 According To Sales - Table: Top 10 INNs and Combinations In Uzbekistan During 2007/2008 According To Sales Company Profiles - Indigenous Companies - Jurabek Laboratories - Uzpharmsanoat - Asklepiy Pharmaceutical Company BMI Methodology - How We Generate Our Pharmaceutical Industry Forecasts - Pharmaceuticals Business Environment Ratings - Risk/Reward Ratings Methodology - Ratings System - Table: Pharmaceutical Business Environment Indicators - Weighting - Table: Weighting Of Components - Sources Forecast Tables About Business Monitor International Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number